May 2018
Recent Advances in the Care of Patients with Chronic Lymphocytic Leukemia (CLL)
May 27, 2018
Article
Continuing Education
Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs
May 24, 2018
Article
Continuing Education
Opioid Addiction and Overdose
May 21, 2018
Article
Chronic Care Focus
Opioid use, abuse, and associated deaths have skyrocketed in the United States over the past decade. Since 1999, the number of opioid-related deaths has quadrupled
Minimizing WAC Exposure to Decrease Drug Expense in the Virtual Inventory Setting
May 19, 2018
Article
Viewpoints
Pre-Exposure Prophylaxis for HIV: Is a Pill the New Condom?
May 08, 2018
Article
Infectious Diseases Focus
Updates in Antimicrobial Stewardship: What Do Health System Pharmacists Need to Consider?
May 05, 2018
Article
Formulary Drug Review
Among the most important initiatives affecting health systems in the United States in 2017 was The Joint Commission (TJC) mandate requiring antimicrobial stewardship (AMS) programs at all acute-care and critical-access hospitals in the country.
Capecitabine and Warfarin Interaction: A Review of Literature and Recommendations
May 03, 2018
Article
Clinical Care Focus
The capecitabine and warfarin interaction is well documented in the literature and has earned a black box warning because of its potential severity.
340B: Emerging From the Shadows
May 01, 2018
Article
Editor’s Note
In this issue of Pharmacy Times® Health-System Edition, Grayson K. Peek, PharmD, and Halena Leah Marcelin, PharmD, offer a brief discussion of optimizing wholesale acquisition cost exposure for organizations participating in the federal 340B drug discount program when the group purchasing organization prohibition requirement applies.